4//SEC Filing
Quartel Adrian W 4
Accession 0001209191-22-012249
CIK 0001069308other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:39 PM ET
Size
5.8 KB
Accession
0001209191-22-012249
Insider Transaction Report
Form 4
Quartel Adrian W
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-21+200,000→ 200,000 totalExercise: $2.55Exp: 2032-02-21→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over four years as follows: 25% of the shares vest on February 21, 2023, and the remaining 75% of the shares vest quarterly over the remainng three years.
Documents
Issuer
Acer Therapeutics Inc.
CIK 0001069308
Entity typeother
Related Parties
1- filerCIK 0001910132
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:39 PM ET
- Size
- 5.8 KB